Corcept Therapeutics
CORT
CORT
135 hedge funds and large institutions have $664M invested in Corcept Therapeutics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 52 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5.64% more ownership
Funds ownership: 48.05% → 53.69% (+5.6%)
0% more funds holding
Funds holding: 135 → 135 (0)
29% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 52
Holders
135
Holding in Top 10
3
Calls
$1.97M
Puts
$224K
Top Buyers
| 1 | +$75.3M | |
| 2 | +$56.7M | |
| 3 | +$8.19M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$7.45M |
| 5 |
Bank of New York Mellon
New York
|
+$4.76M |
Top Sellers
| 1 | -$6.85M | |
| 2 | -$4.71M | |
| 3 | -$3.72M | |
| 4 |
ISL
Ingalls & Snyder LLC
New York
|
-$3.47M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.23M |